# Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

> **NCT01608815** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 200 (actual)

## Conditions studied

- Salmonella Infections
- Typhoid Fever
- Bacterial Infections

## Interventions

- **BIOLOGICAL:** Typhoid Vi polysaccharide

## Key facts

- **NCT ID:** NCT01608815
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608815, "Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01608815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*